Wegovy®
The Novo Nordisk branded semaglutide injector pen, FDA-approved for chronic weight management and cardiovascular risk reduction in adults with obesity. Prescribed online by US-licensed doctors with insurance verification.
- FDA-approved for chronic weight management
- Once-weekly prefilled injector pen
- Average ~15% body weight reduction (STEP 1)
- Insurance billing or NovoCare cash pay options
shipping
doctors
doctor 24/7
- Same price at every dose. No hidden fees.
- Free expedited shipping.
- No membership fees.
- Doctor-led plans, ongoing doctor support.
Why do people explore wegovy® therapy?
Lose the weight with the FDA-approved standard for chronic weight management.
Weight Loss
- Up to 15% body weight
- FDA-approved label
- Pre-measured pens
Cardiovascular Health
- FDA CV risk indication
- SELECT trial backed
- 20% lower CV risk
Metabolic Function
- Better glucose control
- Improved A1C
- Lipid panel gains
Appetite Control
- Slows gastric emptying
- Reduces food noise
- Steady 7-day effect
Lose weight with FDA-approved care.
Wegovy® is the Novo Nordisk pen — same molecule as compounded semaglutide, regulated under a full FDA approval and delivered in five fixed-dose strengths.
Wegovy is brand-name semaglutide manufactured by Novo Nordisk and shipped as a single-use prefilled injector pen. Every pen is factory-sealed, dose-standardized, and produced under FDA-inspected manufacturing. The active molecule is chemically identical to compounded semaglutide — what differs is the regulatory pathway, the pre-measured delivery format, and the FDA-approved indications for chronic weight management and cardiovascular risk reduction.
Your doctor may prescribe Wegovy when you value the FDA approval pathway, qualify for insurance or NovoCare cash-pay coverage, need the 2024 cardiovascular risk-reduction indication, or prefer the convenience of pre-measured pens. The choice is about access, format, and clinical fit — part of our broader approach to weight loss.
Complete a quick online health intake
STEP
1
Share your health profile online. A US-licensed doctor reviews your fit and decides whether peptide therapy is right for you.
Receive your prescription at your door
STEP
2
If approved, your custom prescription ships free and overnight in temperature-controlled packaging, arriving safely at your home.
Get continuous care from your doctor
STEP
3
Message your care team anytime for dose adjustments, check-ins, and ongoing support that keeps you progressing toward your goals.
Why choose Peptide12?
Patients pick us for clinical rigor, transparent pricing, and care that doesn’t disappear after checkout.
FDA-registered pharmacies
Every prescription is compounded by FDA-registered 503A/503B pharmacies. Batch testing and certificates of analysis available on request.
US-licensed doctors
MDs licensed in your state, not just an order form. Your doctor titrates dosing and answers messages directly.
Transparent pricing
One flat price per protocol. No membership fees, no insurance hassle, no surprise charges. HSA and FSA accepted. Cancel anytime.
Care that doesn’t disappear
Message your doctor through your patient portal whenever you need to. Most replies within hours, never longer than 24.
What patients say
Real outcomes from people on this protocol, all under doctor supervision.
“My insurance covered Wegovy after a prior auth and the Peptide12 team handled the paperwork. Down 38 pounds in seven months and the pens are honestly idiot-proof.”
Rachel M.
Charlotte, NC
“I wanted the FDA-approved version specifically. NovoCare got me to $499 a month and the doctor walked me through every titration step. No drama, no guessing.”
Daniel K.
Salt Lake City, UT
“Switched from compounded to Wegovy when my employer added GLP-1 coverage. Same effect, just the convenience of pre-measured pens. The transition was seamless.”
Priya S.
Raleigh, NC
“My cardiologist wanted me on Wegovy specifically for the 2024 CV indication after a stent. Twenty-two pounds down and my lipid panel looks better than it has in a decade.”
Marcus T.
Cincinnati, OH
“Nausea was rough for the first two weeks at 0.25 mg but the support team coached me through it. By week ten I was sleeping better and down two pant sizes.”
Elena R.
Albuquerque, NM
“Forty-seven, sleep apnea, BMI 34. Wegovy plus the diet plan they sent has me down 29 pounds and off my CPAP for now. Worth every dollar of the NovoCare price.”
Brett W.
Boise, ID
Frequently asked questions
Supporting Studies
- 1.Wilding et al. — STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM, 2021)
- 2.Lincoff et al. — SELECT: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (NEJM, 2023)
- 3.Rubino et al. — STEP 4: Continued vs. Discontinued Semaglutide on Weight Maintenance (JAMA, 2022)
- 4.FDA prescribing information — Wegovy® (semaglutide) injection
- 5.NIH MedlinePlus — Semaglutide Injection